1. Shareholders' Meeting Resolution Date: June 17, 2026

2. Names and Titles of Directors Permitted to Engage in Competitive Activities: - Director: Chen Feng-Ming, representative of Teyong Investment Co., Ltd. - Director: Chen Chang-Hao, representative of Taiwei Biotech Co., Ltd. - Director: Li Mao-Sheng, representative of Maosheng Investment Co., Ltd.

3. Permitted Competitive Activities: Projects identical or similar to the company's business scope

4. Duration of Permitted Competitive Activities: During the period of serving as directors of the company

5. Resolution Outcome (Voting Results under Article 209 of the Company Act): Approved as proposed through voting.

6. Directors Engaging in Competitive Activities Related to Mainland China-based Businesses (Enter 'Not Applicable' if not applicable): Not Applicable

7. Company Name and Position Held in Such Mainland China-based Business: Not Applicable

8. Address of Such Mainland China-based Business: Not Applicable

9. Business Scope of Such Mainland China-based Business: Not Applicable

10. Impact on the Company's Financial and Business Operations: Not Applicable

11. If Directors Have Invested in Such Mainland China-based Business, Investment Amount and Shareholding Ratio: Not Applicable

12. Other Matters to Be Disclosed: None

FACT BOX

  • Source: PR Times
  • Category: News